368 related articles for article (PubMed ID: 9158255)
21. [Alpha interferons--new therapeutic modalities].
Bajcetić M; Zigon N; Samardzić R; Beleslin DB
Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956
[TBL] [Abstract][Full Text] [Related]
22. Clinical uses for interferon in the treatment of cancer. A critical review.
Ringenberg QS; Patterson WP
Mo Med; 1988 Jan; 85(1):21-6. PubMed ID: 3277031
[No Abstract] [Full Text] [Related]
23. Interferon alfa-2a.
Williams CD; Linch DC
Br J Hosp Med; 1997 May 7-20; 57(9):436-9. PubMed ID: 9274677
[TBL] [Abstract][Full Text] [Related]
24. Comparative studies of ampligen (mismatched double-stranded RNA) and interferons.
Carter WA; Hubbell HR; Krueger LJ; Strayer DR
J Biol Response Mod; 1985 Dec; 4(6):613-20. PubMed ID: 2418160
[TBL] [Abstract][Full Text] [Related]
25. Biotherapy with interferon in hematologic malignancies.
Roth MS; Foon KA
Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569
[No Abstract] [Full Text] [Related]
26. Interferons in renal-cell carcinoma: status and prospects.
De Mulder PH; Debruyne FM; Beniers AJ
Prog Clin Biol Res; 1990; 348():49-59. PubMed ID: 1696737
[No Abstract] [Full Text] [Related]
27. Studies on antiviral and antitumor effects of human leukocyte interferon in vitro and in vivo.
Strander H; Cantell K
In Vitro Monogr; 1974; (3):49-56. PubMed ID: 4471024
[No Abstract] [Full Text] [Related]
28. [Interferon and therapy of oncological diseases].
Andzhaparidze OG; Pille ER
Vopr Virusol; 1989; 34(5):517-23. PubMed ID: 2481902
[No Abstract] [Full Text] [Related]
29. Alfa interferon: combinations with other antineoplastic modalities.
Bonnem EM
Semin Oncol; 1987 Jun; 14(2 Suppl 2):48-60. PubMed ID: 3296212
[TBL] [Abstract][Full Text] [Related]
30. Interferon: a new name in cancer treatment.
Lancaster J
Nurs RSA; 1987 Feb; 2(2):28-9. PubMed ID: 2438555
[No Abstract] [Full Text] [Related]
31. [Interferon in the treatment of solid tumors].
Lukac J; Seso D; Daković N; Ferencić Z; Cajkovac V; Belicza M; Soos E; Ikić D; Kusić Z
Lijec Vjesn; 1994; 116(11-12):303-7. PubMed ID: 7536287
[TBL] [Abstract][Full Text] [Related]
32. [Human interferons: biological and clinical promises and premises].
Jasmin C
Schweiz Med Wochenschr; 1991 Mar; 121(13):463-6. PubMed ID: 1709521
[TBL] [Abstract][Full Text] [Related]
33. Update on the antitumor activity of alpha interferon.
Quesda JR
Oncology (Williston Park); 1988 Mar; 2(3):49-54. PubMed ID: 3079324
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic use of interferon: current trends and prospects].
Laghi V; Toccaceli F
Medicina (Firenze); 1990; 10(2):201-11. PubMed ID: 1703261
[No Abstract] [Full Text] [Related]
35. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR
Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766
[TBL] [Abstract][Full Text] [Related]
36. Interferons: present and future use in cancer therapy.
Golomb HM
J Clin Oncol; 1986 Feb; 4(2):123-5. PubMed ID: 2418165
[No Abstract] [Full Text] [Related]
37. Interferon in metastatic renal cell carcinoma.
Fosså SD
Semin Oncol; 2000 Apr; 27(2):187-93. PubMed ID: 10768597
[TBL] [Abstract][Full Text] [Related]
38. Interferon-alpha: current status and future promise.
Bonnem EM; Spiegel RJ
J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
[No Abstract] [Full Text] [Related]
39. Non-Hodgkin lymphoma and skin cancer: A dangerous combination.
Otley CC
Australas J Dermatol; 2006 Nov; 47(4):231-6. PubMed ID: 17034463
[TBL] [Abstract][Full Text] [Related]
40. Treatment of neuroendocrine gut and pancreatic tumors with interferons.
Oberg K
Acta Chir Scand Suppl; 1989; 549():56-62. PubMed ID: 2538982
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]